Obstetrics & gynaecology

Sexual minorities at higher risk of teen pregnancy

(HealthDay)—Adolescent sexual minorities other than lesbians use less hormonal contraception and continue to be at an increased risk for teen pregnancy, with the exception of lesbians, according to a study published in ...

Obstetrics & gynaecology

Free postpartum contraception optimizes pregnancy intervals

(HealthDay)—Providing postpartum contraception to low-income women through publicly-funded programs helps avoid short pregnancy intervals, according to research published online July 8 in Obstetrics & Gynecology.

Medications

FDA OKs sale of 'Morning-after' pill without age limit

(HealthDay)—The so-called morning-after pill is about to go over-the-counter, with the U.S. Food and Drug Administration announcing Thursday that it has approved unrestricted sales of Plan B One-Step.

Health

CDC releases modified contraception recommendations

(HealthDay)—The U.S. Centers for Disease Control and Prevention has issued modified recommendations for health care providers regarding the safe and effective use of contraceptive methods; the report, "U.S. Selected Practice ...

Medications

Xgeva approved for rare, non-malignant tumor

(HealthDay)—Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.

Medications

At least 23 Canadian deaths linked to contraceptive

At least 23 Canadian women died and hundreds more may have been harmed taking the world's two most commonly prescribed birth control pills, the country's public broadcaster said Tuesday.

Medications

J&J recalls 32M contraceptive packages outside US

Johnson & Johnson is conducting a voluntary recall of millions of oral contraceptive packages in 43 countries outside the U.S., but the health care giant says there's a "very low" risk that the flawed tablets could cause ...

page 38 from 40